ImageneBio, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| SLATTERY JOSEPH P | — | Purchase | 16,000 | $5.99 | $95,840 | Dec 24, 2025 |
| Marango Jotin | Chief Financial Officer | Award / Grant | 15,776 | — | — | Jul 28, 2025 |
| Wang Jonathan Jian | — | Award / Grant | 971,173 | — | — | Jul 25, 2025 |
| Wang Stephen Hui | — | Award / Grant | 50,144 | — | — | Jul 25, 2025 |
| ORBIMED ADVISORS LLC | — | Award / Grant | 83,611 | $2.49 | $208,191 | Jul 25, 2025 |
| Bonita David P | — | Purchase | 83,611 | $29.90 | $2,499,969 | Jul 25, 2025 |
| Stampacchia Otello | — | Option Exercise | 379 | — | — | Jul 25, 2025 |
| Butler Erin | Principal Accounting Officer | Award / Grant | 3,051 | — | — | Jul 25, 2025 |
| Bonita David P | — | Award / Grant | 153,121 | — | — | Aug 4, 2023 |
| ORBIMED ADVISORS LLC | — | Award / Grant | 153,121 | — | — | Aug 4, 2023 |
| OrbiMed Capital GP VI LLC | — | Award / Grant | 153,121 | — | — | Aug 4, 2023 |
| Bonita David P | — | Award / Grant | 153,121 | — | — | Aug 4, 2023 |
| Bonita David P | — | Purchase | 96,035 | $5.37 | $515,708 | Jun 23, 2022 |
| OrbiMed Capital GP VI LLC | — | Purchase | 23,419 | $3.71 | $86,884 | Jun 22, 2022 |
| Tessier Maude | Chief Business Officer | Option Exercise | 38,915 | $2.94 | $114,410 | Jan 18, 2022 |
| Zhang Xiaoyan Michelle | Chief Scientific Officer | Option Exercise | 964 | $2.15 | $2,073 | Jan 11, 2022 |
| Zhang Xiaoyan Michelle | Chief Scientific Officer | Option Exercise | 1,000 | $2.15 | $2,150 | Dec 10, 2021 |
| Atlas Venture Associates Opportunity I, LLC | — | Sale | 11,989 | $15.03 | $180,195 | Mar 30, 2021 |
| FORMELA JEAN FRANCOIS | — | Sale | 11,989 | $15.03 | $180,195 | Mar 30, 2021 |
| OrbiMed Genesis GP LLC | — | Purchase | 375,000 | $16.00 | $6,000,000 | Mar 30, 2021 |
| Bonita David P | — | C | 130,924 | — | — | Mar 30, 2021 |
| Atlas Venture Associates XI, LLC | — | C | 2,901,609 | — | — | Mar 30, 2021 |
| Stampacchia Otello | — | Award / Grant | 450,000 | $16.00 | $7,200,000 | Mar 30, 2021 |
| FORMELA JEAN FRANCOIS | — | C | 1,099,118 | — | — | Mar 30, 2021 |
| OrbiMed Genesis GP LLC | — | C | 1,470,872 | — | — | Mar 30, 2021 |
| Bonita David P | — | Purchase | 375,000 | $16.00 | $6,000,000 | Mar 30, 2021 |